tbuckley/cabot-search huggingface dataset:
Abstract 4120670: Pericoronary Adipose Tissue Inflammation as a Marker of Increased Coronary Plaque Burden in Patients With Chronic Coronary Artery Disease With Zero Calcium Score
Authors: Kenichiro Otsuka, Hiroki Yamaura, Naoki Fujisawa, Hirotoshi Ishikawa, Kana Hojo, Kotaro Matsumoto, Akihiro Okamoto, Tomohiro Yamaguchi, Shunsuke Kagawa, Takenobu Shimada, Atsushi Shibata, Asahiro Ito, Takanori Yamazaki, Daiju Fukuda
Journal: Circulation (2024)

Background: Dysfunctional or excess adiposity plays pivotal role in the development of coronary atherosclerosis. It remains unclear whether pericoroanry adipose tissue (PCAT) inflammation is associated with increased coronary plaque burden in its early stage of atherosclerosis, independent of traditional coronary risks or cardiovascular-kidney metabolic health. Purpose: To investigate the association of PCAT inflammation with coronary plaque burden in patients with newly suspected with chronic coronary artery disease (CAD) and zero calcium score who underwent coronary computed tomography angiography (CCTA). Methods: This retrospective CCTA study consists of 294 chronic CAD patients with zero calcium score (59 years, male 51 %). Chronic CAD was defined as stable condition with presence of increased non-calcified plaque burden on CCTA (Figure 1A-D). PCAT attenuation (PCATA) was assessed by fat attenuation index in the major three coronary arteries (right coronary artery, RCA; left anterior descending artery; LAD, and left circumflex coronary artery, LCX)(Figure 1C and D). Multivariable analysis using linear regression model was performed to determine independent predictors of increased %PV by adjusting for traditional coronary risks, metabolic risks, and chronic kidney disease (CKD). Hisayama Risk Score (HRS) was calculated to estimate 10-year cardiovascular risks. Results: Mean %plaque volume (PV) and PCATA-RCA was 44±4.0％ and -77±8.8 HU. %PV was correlated with age (p&lt;0.05), systolic blood pressure (p&lt;0.05), non-HDL cholesterol (p&lt;0.05), Hisayama risk score (p&lt;0.05, Figure 2), PCATA-RCA (p&lt;0.001, Figure 3), PCATA-LAD (p&lt;0.001), and LCX-PCATA (p&lt;0.001). In a multivariable linear regression model adjusting for age, sex, hypertension, diabetes, dyslipidemia, and current smoking (model 1), PCATA-RCA was independently associated with %PV [beta, 0.17; 95% confidential interval (CI) 0.115-0.217, p &lt; 0.001]. In a model adjusting for age, sex, metabolic syndrome, body mass index ≥23kg/mm 2 , and CKD (model 2), PCATA-RCA (beta, 0.18; 95% CI 0.128-0.232, p&lt;0.001) and high-risk HRS (beta, 3.1; 95% CI 1.35−4.87, p&lt;0.001) were independently associated with %PV. Similarly, independent associations of PCATA in LAD and LCX with %PV was observed. Conclusion: This study demonstrates that PCATA is a robust marker related to increased burden of coronary atherosclerosis even in the early stage of atherosclerosis as defined by zero coronary artery calcium score.
Abstract 4119869: Automatic assignment of CAD-RADS categories in coronary CTA reports using large language model
Authors: Yuli Wang, Wen-Chi Hsu, Yuwei Dai, Victoria Shi, Gigin Lin, Harrison Bai, Cheng Ting Lin
Journal: Circulation (2024)

Background: The effectiveness of different large language models (LLM) in extracting important information from CT angiography (CTA) radiology reports is unknown. Purpose: The Coronary Artery Disease-Reporting and Data System (CAD-RADS) is a standardized reporting system for CTA that categorizes the severity of coronary artery disease to aid in clinical decision-making. To evaluate the agreement between human readers and LLMs in assigning CAD-RADS categories based on CTA reports. Materials and Methods: This retrospective study analyzed reports from patients who underwent coronary CTA for screening or diagnosis at Johns Hopkins Hospital. Reports with CAD-RADS 0–5 findings were collected from Jan. 2020 to Oct. 2023. Initially, 6,212 CTA reports were retrieved. After excluding non-organized reports and retaining only those with CAD-RADS scores, 590 reports remained. Board-certified radiologists and three large language models (GPT-3.5, GPT-4, and Llama3) assigned CAD-RADS categories based on the original radiologists' findings. Two radiologists reviewed the CAD scores, with only one discrepancy in the 590 reports, indicating high inter-agreement. Agreement between human readers and LLMs for CAD-RADS categories was assessed using the Gwet agreement coefficient (AC1 value). Frequencies of changes in CAD-RADS category assignments that could potentially affect clinical management (CAD-RADS 0-2 vs. 3-5) were calculated and compared. Typically, CAD-RADS 0-2 indicates mild disease leading to conservative management, while CAD-RADS 3-5 denotes further testing or disease requiring aggressive intervention to prevent adverse cardiovascular events. Results: Among 590 reports, agreement between original and reviewing radiologists was almost perfect (AC1 = 0.985). Good agreement was also found between original radiologists and Llama3, GPT-3.5, and GPT-4 (AC1 = 0.861, 0.907, 0.941, respectively). Differences in CAD-RADS category upgrades/downgrades potentially affecting clinical management were observed: 0 of 590 (0%) for human readers, 56 of 590 (9.4%) for Llama3, 33 of 590 (5.5%) for GPT-3.5, and 23 of 590 (3.9%) for GPT-4 upgrading CAD-RADs; 8 of 590 (1.4%) for human readers, 19 of 590 (3.2%) for Llama3, 22 of 590 (3.7%) for GPT-3.5, and 12 of 590 (2.0%) for GPT-4 downgrading RAD-CADs. Conclusion: LLMs showed good agreement with human readers in assigning CAD-RADS categories on CTA reports. However, they were more likely to upgrade CAD-RADS category when compared to radiologists.
Abstract 4119146: Pulmonary Artery Enlargement Predicts Mortality in Patients with Severe Aortic Stenosis after Transcatheter Aortic Valve Replacement.
Authors: Dionysios Adamopoulos, Christina Gkotsoulia, Hajo Muller, Jean-Paul Vallee, Lindsey Crowe, Jean-Francois Deux, Sarah Mauler-Wittwer, Frederic Lador, Francois Mach, Stephane Noble
Journal: Circulation (2024)

Background: Pulmonary hypertension is associated with extensive remodeling of the pulmonary tree, with key finding the enlargement of the pulmonary artery (PA). Although the independent predictive value of the pulmonary hypertension in patients undergoing transcatheter aortic valve replacement for severe aortic stenosis has been clearly demonstrated, data about the potential predictive value of the pre-interventional PA enlargement on mortality are scarce. Research questions: The aim of the present study was to assess the prognostic significance of the pre-interventional PA enlargement, assessed by cardiac CT scan, in patients undergoing transcatheter aortic valve replacement for severe aortic stenosis. Methods: We conducted a retrospective study and recruited 337 patients with aortic stenosis, who underwent a right heart catheterization and a cardiac CT scan before the transcatheter aortic valve replacement. The cohort was divided in two groups according to the presence of an enlarged PA (PA e ), (main PA axial diameter ≥ 29 mm for males and ≥ 27 mm for females, n=192, mean age 83±6 years, 41% males) or not (PA n ), ( n=145, mean age 84±6 years, 46% males). The primary endpoint was all-cause mortality at 1 year. Results: Globally, a strong correlation between invasive mean PA pressure and main PA axial diameter was noted (Pearson r=0.393, p&lt;0 .001). Compared to the PA n group, patients with enlarged PA exhibited higher 1 year mortality rates (hazard ratio 2.51, 95% CI: 1.1-6.04, p=0.027). The prognostic significance was even stronger after indexing the PA to the ascending aorta diameter (hazard ratio 3.82, 95% CI: 1.86-7.87, p&lt;0.001, figure 1). Conclusions: Pre interventional PA enlargement, is strongly associated with 1-year all-cause mortality in patients undergoing transcatheter aortic valve. This may pave the way for a more precise non-invasive risk stratification in patients with severe aortic stenosis.
Abstract 4120657: A Personal Risk Assessment Device in Patients with Chest Pain
Authors: Alexei Shvilkin, Natasa Zlatic, Vladimir Atanasoski, Sanja Grujovic-Zdolsek, Lana Popovic-Maneski, Marjan Miletic, Vladan Vukcevic
Journal: Circulation (2024)

Introduction: Early prehospital chest pain assessment improves acute coronary syndrome (ACS) outcomes and can reduce unnecessary Emergency Room (ER) visits but requires medical personnel and electrocardiographic (ECG) equipment. Objective: To evaluate the feasibility of a personal credit-card sized chest pain self-assessment device (HeartBeam, Santa Clara, CA, USA) in diagnosing ACS. Methods: ACS risk was estimated by serial likelihood ratio analysis of 3 components: pre-existing coronary heart disease (CHD) risk (pre-calculated based on pooled ASCVD equation), chest pain characteristics (interactive proprietary questionnaire), and integrated near-orthogonal 3-lead self-recorded vectorcardiogram (VCG) with optional comparison to baseline using portable handheld HeartBeam recorder. Final ACS risk was graded High/Intermediate/Low by the cloud-based proprietary algorithm. High risk was considered positive for ACS. Results: 184 ER patients with chest pain (Age 57 +/- 7years, 90 Male, 43 (23%) ACS) comprised learning (n=96) and test (n=88) sets. ACS sensitivity was 28/28 (100%) in learning and 15/16 (94%) in test set with specificity of 43% and 42% respectively. In the subset of patients with pain-free portable VCG recorded 9 months later used as a “reverse baseline” (n=110) sensitivity was 17/17 (100%) and 11/12 (92%), specificity 54% and 58% in learning and test set, respectively (p&gt;0.1 with no baseline). Single patient missed by the analysis had known coronary disease with usual anginal episode resulting in minor troponin leak. In “reverse baseline” analysis 41/110 (37%) patients were classified as Low risk compared to 18/184 (10%) without baseline (p&lt;0.001), all negative for ACS. Based on the analysis of CHD risk factors, chest pain characteristics, and 12-lead ECG, a consensus of 3-member ER chest pain unit physicians panel had sensitivity/specificity of 94/54% for the whole and 93/48% for the “reverse baseline” groups (p&gt;0.1 with HeartBeam device). Conclusion: HeartBeam chest pain self-assessment device provides accurate ACS detection comparable to expert ER physicians using 12 lead ECG. The presence of baseline recording reduces the number of false positive results. If confirmed in larger studies, it can be used to facilitate outpatient chest pain assessment and triage by remote physicians and patients themselves.
Abstract 4119926: Inadequate calorie and macronutrient intake in a population with congestive heart failure in a non-cardiovascular tertiary hospital.
Authors: Tania Godinez Flores, Clemente Barron, Gerardo Payró, LILIA CASTILLO MARTINEZ
Journal: Circulation (2024)

Introduction: Chronic Heart Failure (HF) is a clinical syndrome that as a consequence of the compensatory mechanisms to maintain an adequate level of perfusion, causes dyspnea, peripheral edema, fatigue, lack of appetite, changes in body weight, cachexia, sarcopenia, among others. The presence of these signs and symptoms, with other factors such as restrictions on salt and water consumption, early satiety, and poor mobility, producing changes in the patient's nutritional status that can indirectly increase the risk of inadequate dietary intake, which over a prolonged period will lead to the development of nutritional deficiencies. Objective: To analyze the dietary intake of energy, macronutrients, and micronutrients of patients with chronic HF in outpatient care. Methods: Cross-sectional study, including 75 outpatients with HF, who attended a Heart Failure Clinic. Data collection on dietary intake was obtained using a multi-step 24-hour recall. The ESHA Food Processor program was used to calculate the energy, macronutrient, and micronutrient intake. The presence of congestion was evaluated by bioelectrical impedance vectorial analysis and VEXUS. Results: The baseline characteristics of the population are shown in Table 1. Of the total population, 34% presented with deficient caloric intake, and the subjects who presented congestion also ingested significant fewer calories compared with those who do not present congestion (p= 0.031). Only 15% of patients had an adequate protein intake that resulted in lower NYHA class; among those subjects with a deficient protein intake, 72% had congestion measured by VExUS or bioelectrical impedance. For the sodium intake in the subjects' diet, 45% exceeded the recommendation stated in the guidelines of less than 2,400 mg of sodium per day which was not statistically significant (p=0.077). Discussion and Conclusions: The inadequate intake of calorie or macronutrients in patients with CHF led the patients to more congestion and higher NYHA class, this provide a perspective on the importance of adequate nutritional advice by an expert in the area, which is also essential to improve the clinical course of heart failure. Likewise, future studies are deeded to investigate whether this poor dietary intake is inversely related to some clinical manifestations such as congestion, suggesting that improving these conditions could positively impact patients' volume status and improve functional class.
Abstract 4115531: Relationship between Ventricular Workload and Functional Response to Balloon Pulmonary Angioplasty (BPA) Therapy for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Authors: Nicole Nashed, Lawrence Ang, Alma Fregoso, Jonathan Omens, Taylor Buchalla, Paul Chavez, David Poch, JENNY YANG, Hyong Kim, Ehtisham Mahmud
Journal: Circulation (2024)

Background: WHO functional classification (FC) is used to evaluate clinical response to BPA therapy and is associated with hemodynamic improvements in CTEPH patients. The relationships between FC and specific metrics of left and right ventricular workload during BPA remain unclear. Methods: CTEPH patients who underwent at least six BPA sessions and were included in the UCSD BPA registry were included for analysis. Left ventricular (LV) and right ventricular (RV) cardiac power output (CPO) and stroke work index (SWI) using thermodilution cardiac output were measured, along with FC, during each BPA session. BPA “responders” showed improved FC from III/IV at baseline to I/II after BPA therapy. BPA “non-responders” had unchanged FC III/IV symptoms before and after BPA therapy. ANOVA and Student T tests were used and P-value &lt;0.05 was significant. Results: A total of 66 subjects (55.5% female, BMI 28.3±6.10kg/m 2 ,16.7% prior pulmonary thromboendarterectomy surgery) were enrolled. Greater subject functionality by FC was significantly associated with higher LVCPO (class IV to I: 0.88±0.15, 0.94±0.28, 1.08±0.31, 0.95±0.27 watt; p&lt;0.001), higher LVSWI (29.4±6.6, 35.6±9.4, 40.8±8.8, 43.4±11.1 g*m/beat/m 2 ; p&lt;0.001), and lower RVCPO (0.37±0.10, 0.34±0.12, 0.34±0.14, 0.24±0.09 watt; p=0.003). RVSWI was not significantly associated with FC (14.8±3.7, 15.4±5.1, 15.1±5.0, 12.5±3.3 g*m/beat/m 2 ; p=0.075). Likewise, higher mean LVCPO (1.1±0.30 vs 0.93±0.27 watt; p&lt;0.001) and LVSWI (41.1±9.1 vs 35.2±9.4 g*m/beat/m 2 ; p&lt;0.001), but not RVCPO or RVSWI, were observed in subjects with FC I/II versus FC III/IV symptoms. BPA responders versus non-responders had higher overall LVCPO (1.01±0.27 vs 0.89±0.27 watt; p&lt;0.001) and LVSWI (39.0±8.9 vs 33.2±8.4 g*m/beat/m 2 ; p&lt;0.001), but not RVCPO (0.33±0.13 vs 0.34±0.13 watt; p=0.465) or RVSWI (15.2±4.8 vs 14.9±5.1 g*m/beat/m 2 ; p=0.694). Responders also had higher baseline LVSWI (p=0.029) and post-BPA LVSWI (p=0.028) compared to non-responders. Conclusions: CTEPH patient functionality and symptoms during BPA therapy are associated with metrics of left and right ventricular workload. Patients with more severe FC III/IV symptoms produce lower LV workload. Treatment responders with improved FC after BPA therapy achieve higher overall, pre-BPA, and post-BPA LV workload. Specific metrics of ventricular workload may be helpful determinants of CTEPH patient symptoms and BPA treatment response.
Abstract 4119167: Electromagnetic Interference from Electric Vehicles: Implications for Subcutaneous Implantable Cardioverter-Defibrillators
Authors: Kamil Salam, Anmar Salih, Tarun Goswami, Abdul Wase
Journal: Circulation (2024)

Background: Electromagnetic interference (EMI) refers to signals discernible by a device’s circuitry, potentially resulting in erroneous sensing, pacing, mode switching and defibrillation. EMI poses potential risks to the functionality of cardiac implantable electronic devices, with Subcutaneous- Implantable Cardioverter-Defibrillators (S-ICDs) potentially more susceptible due to their design. Research Question: Does EMI from Electric Vehicles (EV) interfere with the functionality of S-ICDs? Goals: Developing and utilizing a loop antenna device that mimics S-ICDs to assess the susceptibility of S-ICDs to EMI from EVs in different charging conditions. Methods: A loop antenna device mimicking the S-ICD lead design was developed, and then validated by the Food and Drug Administration, to detect electromagnetic signals. The device was positioned at different locations in a Tesla Model 3 to measure electromagnetic signals. Results: Statistical analysis revealed a significant difference (p-value &lt; 0.0001) in detected voltage (400-504 mV) around the cup holder compared to all other measured locations. These signals fell within the R-Wave Spectrum of 30-300 Hz. Conclusion: We identified EV-emitted EMI capable of disrupting S-ICD functionality. Further in-vivo studies are essential to determine the level of interference between S-ICDs and EMI from EVs.
Abstract 4118018: Increased Risk of Post-Transplant Malignancy After Isolated Heart Transplant in Adult Patients with Congenital Heart Disease
Authors: Orly Leiva, Stephanie Golob, alex reyentovich, Jose Alvarez-Cardona, Michelle Bloom, Dan Halpern, Adam Small
Journal: Circulation (2024)

Introduction: Patients with congenital heart disease (CHD) are at increased risk of cancer. In patients with CHD and advanced heart failure, isolated heart transplantation (HT) can be considered. In the overall HT population, immunosuppression after HT increases the risk of post-transplant malignancy (PTM). However, cancer outcomes among adult HT patients with CHD have not been investigated. Methods: Patients aged ≥ 18 years who received HT between January 1, 2010 and December 31, 2021 were identified using the United Network for Organ Sharing (UNOS) registry. Patients with CHD were compared to those without. Outcomes were PTM and hematologic malignancy (either leukemia, lymphoma or post-transplant lymphoproliferative disorder). Multivariable Fine-Gray competing-risk regression adjusting for age, sex, race, prior cardiac surgery, smoking, diabetes, induction immunosuppression, recipient and donor cytomegalovirus and Ebstein-Bar virus status was used to estimate subhazard ratio (SHR). Results: Of the total of 29,717 patients with HT were included, 1,017 (3.4%) had CHD. Patients with CHD were younger, more likely to be female, and more likely to have had prior cardiac surgery. After multivariable competing-risk regression, CHD was associated with higher risk of PTM (aSHR 1.44, 95% CI 1.15 – 1.80) and hematologic malignancy (aSHR 2.09, 95% CI 1.28 – 3.42). Among patients &lt; 45 years old, CHD had an unadjusted SHR of 1.55 (95% CI 1.11 – 2.16) of PTM, Figure. Conclusions: Among adult patients with HT, CHD was associated with increased risk of PTM and hematologic malignancy. Further investigation is warranted to identify risk factors and screening strategies for malignancy in this patient population.
Abstract 4114372: Is Takotsubo syndrome associated with a favorable in-hospital outcome among patients with cardiogenic shock? A propensity score-matched analysis of the National Inpatient Sample Data (2016-2020)
Authors: Bekure Siraw, Hong Thoai Nguyen, Hemraj Paudel, Juveriya Yasmeen, Mohammed Hussein, Jose Medina-Inojosa, Khalid Hussein, Kirthi Somarouthu, Satish Bastola
Journal: Circulation (2024)

Background: Takotsubo cardiomyopathy (TTC) is characterized by impaired left ventricular function due to typical, regional wall motion abnormalities in the absence of significant obstructive coronary artery disease. Previous small-sized retrospective studies reported favorable outcomes of cardiogenic shock in patients with TTC. We aimed to investigate whether the presence of TTC is associated with a favorable in-hospital outcome among patients admitted for cardiogenic shock using a large nationally representative dataset. Methods: Utilizing data from the National Inpatient Sample (NIS) spanning from 2016 to 2020, we identified patients admitted for cardiogenic shock using ICD-10 codes. Patients with TTC were also identified using ICD-10 codes. Using sociodemographic variables, and comorbid medical conditions, and performed procedures as matching variables, we conducted a 1:1 nearest-neighbor propensity score matching to mitigate potential confounders. The success of matching was evaluated based on standardized mean differences. In-hospital mortality was the primary outcome, while in-hospital complications, length of stay (LOS), and cost of hospitalization were secondary outcomes. We employed the Cochrane-Mantel-Haenszel method to assess the odds ratio (OR) for in-hospital mortality and complications. Simple linear regression models were used to evaluate differences in LOS and cost of hospitalization. Results: The final sample included 22,594 patients, evenly distributed between the groups with and without TTC. The mean age of the cohort was 65.4 years (SD = 15.9), with 74.7% being males. Ethnic composition indicated 75.7% Whites, 9.3% Blacks, and 8.1% Hispanics. The overall in-hospital mortality rate was 32.7%. The TTS group had a lower mortality rate (38.4% Vs 27%, p&lt;0.001). Patients with TTC had lower odds of in-hospital mortality, cardiac arrest, ventricular tachycardia, and acute kidney injury. However, they were noted to have higher odds of deep vein thrombosis, stroke, slightly higher LOS, and cost of hospitalization. Conclusion: In summary, our study suggests that Takotsubo Cardiomyopathy is associated with significantly lower in-hospital mortality rates among patients admitted for cardiogenic shock, indicating a favorable prognosis in this clinical setting.